石药集团巨石生物制药有限公司

Country

Ownership: -

Established: 2019-04-16

Employees: -

Market Cap: -

Website: www.e-cspc.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Omalizumab for Injection

Product Name: 恩益坦

Approval Number: 国药准字S20240043

Approval Date: Sep 26, 2024

NMPA

Enlonstobart Injection

Product Name: 恩舒幸

Approval Number: 国药准字S20240028

Approval Date: Jun 25, 2024

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.